Glassman Wealth Services’s Gossamer Bio GOSS Stock Holding History

Glassman Wealth Services’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-24	Closed	–	–	1416
2020 Q3	$0	Hold	24	–	–	﹤0.01%	1390
2020 Q2	$0	Buy	+24	New	+$302	﹤0.01%	1343

Other funds holding GOSS

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Glassman Wealth Services's GOSS Position: Q4 2020 in Review

Glassman Wealth Services sold out of Gossamer Bio (GOSS) in Q4 2020, closing a stake of 24 shares.

Glassman Wealth Services first reported a position in GOSS in Q2 2020 and held it in 2 quarters. The position peaked at $0 in Q3 2020. 122 funds tracked by Wall St. Rank hold GOSS as of Q4 2020.

Glassman Wealth Services reported no remaining Gossamer Bio position as of Q4 2020 after selling out during the quarter.
Glassman Wealth Services sold 24 Gossamer Bio shares in Q4 2020.
Glassman Wealth Services first reported a position in Gossamer Bio in Q2 2020 and held it in 2 quarters.
Glassman Wealth Services's Gossamer Bio position peaked at $0 in Q3 2020.
122 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2020.

Based on Glassman Wealth Services's 13F filing for Q4 2020, filed 4 Feb 2021.